Tigecycline: Place in therapy and important considerations

American Journal of Health-System Pharmacy

Volumn 63, Issue 13, 2006, Pages 1233-

  Garrelts, James C ^a   Schroeder, Todd ^a  

^a WESLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; OXACILLIN; PENICILLIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TIGECYCLINE;

ABDOMINAL INFECTION; ACINETOBACTER; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEROIDES FRAGILIS; CHLAMYDOPHILA PNEUMONIAE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG WITHDRAWAL; EDITORIAL; ENTEROBACTERIACEAE; FOOD AND DRUG ADMINISTRATION; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NAUSEA; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; STENOTROPHOMONAS MALTOPHILIA; VANCOMYCIN RESISTANT ENTEROCOCCUS; VOMITING;

EID: 33745767756     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060206     Document Type: Editorial

References (5)

1. Zinner SH. Overview of antibiotic use and resistance: setting the stage for tigecycline. Clin Infect Dis. 2005; 41(suppl 5):S289-92.
2. Infectious Diseases Society of America. Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. www.idsociety.org/pa/ IDSA_Paper4_final_web.pdf (accessed 2006 Apr 11).
3. Kasbekar N. Tigecycline: a new glycylcycline antimicrobial agent. Am J Health-Syst Pharm. 2006; 63:1235-43.
4. Noskin GA. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis. 2005; 41(suppl 5):S303-14.
5. Guay DR. Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria. Pharmacotherapy. 2004; 24:58-68.